A novel Ligand‐based TSH‐CAR‐T cell approach effectively eradicated TSHR‐positive thyroid tumors in vitro and accomplished full remission in tumor models with favorable safety profile, highlighting that TSH‐CAR‐T cells could represent a promising new therapeutic option for patients with advanced DTC. The gene discussed is TSHR; the disease is neoplasm.